Turkish Abstract Abstract Article PDF Similar Articles Mail to Author

¹M.D. Asistant Professor, Fırat University Faculty of Medicine, Department of Ophthalmology, Elazığ/TURKEY
²M.D. Asistant, Fırat University Faculty of Medicine, Department of Ophthalmology, Elazığ/TURKEY
³M.D. Professor, Fırat University Faculty of Medicine, Department of Ophthalmology, Elazığ/TURKEY
⁴M.D. Associate Professor, Fırat University Faculty of Medicine, Department of Ophthalmology, Elazığ/TURKEY DIDMOAD Syndrome (Wolfram Syndrome) is presented with diabetes insipidus, diabetes mellitus, optic atrophy, and deafness at childhood. We evaluated the anatomic and functional responses after bilateral intravitreal injection of bevacizumab for a pediatric patient with DIDMOAD Syndrome and proliferative diabetic retinopathy at follow-up in our clinic. Especially, in the patients with vitreous hemorrhage and/or child cases which panretinal laser photocoagulation can not be completed or performed, intravitreal bevacizumab injection can be performed as an effective and safe treatment. Keywords : Bevacizumab, proliferative diabetic retinopathy, panretinal laser photocoagulation